Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Abbott ID NOW CoV-2 molecular point-of-care test for novel coronavirus

Abbott has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes.

What makes this test so different is where it can be used: outside the four walls of a traditional hospital such as in the physicians' office or urgent care clinics.

The new Abbott ID NOW COVID-19 test runs on Abbott's ID NOWTM platform--a lightweight box (6.6 pounds and the size of a small toaster) that can sit in a variety of locations.

Because of its small size, it can be used in more non-traditional places where people can have their results in a matter of minutes, bringing an alternate testing technology to combat the novel coronavirus.

We're ramping up production to deliver 50,000 ID NOW COVID-19 tests per day, beginning next week, to the U.S. healthcare system.

This comes on the heels of our announcement last week of the availability of the Abbott RealTime SARS-CoV-2 EUA test under FDA EUA, which runs on m2000 RealTime molecular system for centralized lab environments. Combined with ID NOW, Abbott expects to produce about 5 million tests in April.

How It Works: Portable Coronavirus Teating

Formerly AlereTM i. New and Improved Speed, Performance and Efficiency. Plus a new name.

Reviews: "The Alere I is constantly being sent in for service. The touch pad stops working at regular intervals. The mechanical parts of the machine break often. I have the machine for free if I buy test kits. If I had purchased the machine outright I would have been fuming mad."

by Oui on Sat Mar 28th, 2020 at 03:48:54 PM EST
[ Parent ]


Occasional Series